Back to search results

Evaluating an Educational Website for Colorectal Cancer Survivors

This study is testing an educational website called Current Together After Cancer (CTAC) to see if it helps people who have had surgery for Stage II or Stage III colorectal cancer get the recommended follow-up care. Many survivors don't receive this important care, which helps find if cancer returns. The CTAC website aims to give you and a supporter in your life more knowledge and confidence about managing your follow-up care. You would either get access to the CTAC intervention website with educational content or a control website with general health information. Researchers will then see if those using the CTAC intervention website receive more guideline-recommended surveillance care. This study is looking for about 1057 participants.

Study design
This interventional study will involve about 1057 participants. You would be randomly assigned to receive access to either the CTAC intervention website or a control website.
What's involved
You would access an educational website. There will also be interviews and questionnaires to complete, likely at 3 and 16 months after joining the study.
Compensation
Not stated in the trial record.
Follow-up
Your colorectal cancer surveillance will be measured at 16 months after joining the study. Your knowledge and self-efficacy will be assessed at 3 and 16 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07018869

Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors

Recruiting
PHASE3Ages 18+InterventionalHealth services
SWOG Cancer Research Network
~1,057 participants
Updated 2026-03-31 on ClinicalTrials.gov
What's tested:Intervention website accessControl website accessInterviewQuestionnaire Administration

At a glance

Recruiting sites
383 of 384 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Receipt of colorectal cancer surveillance
Measured over At 16 months

Conditions

Colorectal Cancer Stage II
Colorectal Cancer Stage III

Explore related trials

Colorectal Carcinoma

Where it's being run

384 sites across 36 states
Michigan56
Minnesota41
Illinois36
Missouri22
Washington20
Wisconsin19
Iowa18
South Carolina17

Study leadership

  • Christine M Veenstra · PRINCIPAL_INVESTIGATOR · SWOG Cancer Research Network

Who to contact

Site Public Contact
[email protected]
907-212-6871
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

PATIENTS:
Patient participants must have newly diagnosed surgically resected, stage II or stage III colorectal cancer per the timing described below
Patient participants must have an adult in their life who supports them in their colorectal cancer journey who they might be willing to invite to join them in viewing an educational website. This is determined via the question: "Do you have an adult in your life, such as a spouse/partner, family member or friend, who supports you with your colorectal cancer journey and may be willing to view a website with you? When we say, "supports you in your colorectal cancer journey", we mean things like, helping you keep and get to medical appointments, talking with you and/or your doctors about your cancer, or helping you make decisions about your cancer."
Those who respond "no" to the question above will be told that "Because this study is for patients and a supporter to view the website together, you are not eligible for this study, but there may be other studies you are eligible for in the future".
NOTE: The above question will be used to define "supporter" for purposes of this study. Examples of supporters include a spouse, partner, sibling, adult child, another family member, or friend.
NOTE: The supporter does not have to agree to participate in the study in order for the patient to be eligible for this study. Justification for requiring the enrolled patient to have a supporter (whether the supporter is invited or participates) is based on the study's underlying conceptual framework
Patient participants must not have recurrent or metastatic (stage IV) colorectal cancer
Patient participants must not have a prior or concurrent malignancy whose natural history or treatment (in the opinion of the treating physician) has the potential to interfere with the efficacy assessment of this intervention
Patient participants must be registered within 90 - 180 days of surgical resection
Patient participants must be ≥ 18 years of age at the time of registration/randomization. The lower cutoff of 18 was determined because the lower age range of patients that may be recruited to Southwest Oncology Group (SWOG) studies is 18
Patient participants must have Zubrod performance status of 0-2
Patient participants must be able to read English or Spanish since the website for the intervention and control arm are available in English and Spanish
Patient participants must: 1) be able to complete Patient Reported Outcome (PRO) questionnaires in English or Spanish, and 2) agree to complete PROs at all scheduled timepoints
Patient participants will be encouraged to provide an email address or cell phone number, if possible, for the purpose of being contacted by staff at the University of Michigan who will provide access to the educational website. For those who do not wish to provide or create an email address or a cell phone number, they may still participate with alternate methods
Patient participants must not be enrolled or be planning to enroll in a clinical trial of investigational treatment that includes imaging and/or laboratory monitoring for the duration of this trial
NOTE: Patient participants are allowed to be co-enrolled on other non-treatment clinical trials
SUPPORTER PARTICIPANT:
Supporter participants must be ≥ 18 years of age at the time of registration/randomization
Supporter participants must be able to read English or Spanish since the educational website is available in English and Spanish
Supporter participants must have been identified by the patient as a person who may be willing to join them in reviewing the educational website
PATIENT AND SUPPORTER:
NOTE: As a part of the Oncology Patient Enrollment Network (OPEN) registration process the treating institution's identity is provided in order to ensure that the current (within 365 days) date of institutional review board approval for this study has been entered in the system
Patient and supporter participants must be informed of the investigational nature of this study and must sign and give informed consent in accordance with institutional and federal guidelines. This protocol does not permit use of Legally Authorized Representative

What this trial measures

  • Receipt of colorectal cancer surveillanceAt 16 months

    Receipt of the four surveillance components will be abstracted as a binary outcome (yes versus no) from the electronic medical record for every enrolled patient. Additionally, patient-reported receipt of surveillance will be collected via survey. Multivariable logistic regression will be used, adjusted for the stratification factors as covariates.